skip to main content

ProfessionalsMegan F. Raymond

Megan F. Raymond
Counsel

Tel: +1-202-223-7401
Fax: +1-202-403-3777
mraymond@paulweiss.com

+1-202-223-7401
Washington

2001 K Street, NW
Washington, DC 20006-1047
Fax: +1-202-403-3777

+ vCard ADD TO CONTACTS
Education 
Clerkship 
Bar Admissions 
Education 
Clerkship 
Bar Admissions 

As counsel in the Litigation Department, Megan Raymond focuses on patent infringement matters. Megan has significant experience representing clients in post-grant proceedings before the Patent Trial and Appeal Board (PTAB), and has been involved in over 90 proceedings to date. Megan also has experience litigating in a number of significant patent jurisdictions, including Delaware, New Jersey, Texas, the U.S. Court of Appeals for the Federal Circuit and the International Trade Commission. She regularly manages coordination between PTAB proceedings and district court proceedings.

EXPERIENCE

Serving clients like Genzyme, Twitter, and Garmin, Megan has litigated in a variety of technical fields, including biotechnology, electronics, consumer products, internet technology, computer software, mobile devices, and cryptography.

Her recent experience includes:

  • Chugai Pharmaceutical in a significant pair of inter partes review victories against a major pharmaceutical company, defending two of its patents relating to new, simpler, less costly methods of removing DNA contaminants from proteins, a key step in the production of genetically engineered and biologic drugs. The three-judge tribunal issued final written decisions rejecting the major pharmaceutical company’s arguments, finding they had failed to show that any of the challenged claims in the two Chugai patents were unpatentable.
  • A major biotechnology company in a significant inter partes review (IPR) win at the Patent Trial and Appeal Board (PTAB). The proceeding sought to invalidate a patent directed to treating patients with rheumatoid arthritis, and in a final written decision the Board found the challenger, a major pharmaceutical company with a proposed biosimilar product, had failed to show any of the challenged claims to be unpatentable.
  • A Leading U.S. Consumer Electronics Company in successfully pursuing a collection of more than 40 CBM petitions that together invalidated every claim (more than 150 in total) of seven litigated patents relating to the sale of digital content over the Internet. This included a group of claims that had led to a $533 million jury verdict in district court.
  • A Leading Global Pharmaceutical Company in the preparation of an IPR petition challenging a patent relating to a method for injecting Botox® into spinal muscles for pain treatment. The Board granted institution on all challenged claims.
  • A Leading U.S. Consumer Electronics Company in the preparation of four petitions for CBM review challenging two litigated patents relating to selling digital music electronically. The PTAB invalidated all challenged claims in its final decision. On appeal, the Federal Circuit affirmed the Board’s decision and denied the Patent Owner’s requests for rehearing and rehearing en banc.
  • Spansion Inc. in multi-patent infringement cases involving non-volatile memory technology in district court and the ITC. Successfully obtained transfer to the Northern District of California from the Eastern District of Virginia.
  • PerkinElmer, Inc. in district court litigation involving a patent concerning the method of administering pre-natal Down syndrome screening. Patent was successfully invalidated on summary judgment. Decision was affirmed on appeal.
  • Braemar Manufacturing in IPR proceedings relating to cardiac monitoring technology. Institution was successfully denied.

Megan is ranked in Chambers USA as an Up and Coming practitioner for Intellectual Property: Patent. Chambers describes her having particular expertise in PTAB proceedings and describes her as “a very smart and capable lawyer, who represents clients in a very effective way.” Megan has also been recognized by The Legal 500 for her patent litigation work and was named to the PTAB Bar Association's “Top 50 Women in PTAB Trials” list in 2019.

Megan currently serves on the Board of the PTAB Bar Association. Megan is also the chair of the Federal Circuit Bar Association’s PTAB committee and the vice-co-chair of the Federal Circuit Bar Association’s Mock Argument Committee. She previously served as the vice-chair of the PTAB Bar Association’s Programming Committee and Women’s Committee. On the Women’s Committee she worked on preparing the PTAB Bar Association Women at the PTAB report on gender diversity in the PTAB. She received the Federal Circuit Bar Association’s George Hutchinson Committee Award recognizing committee leadership in 2017, 2018, and 2019. She is a frequent speaker on developments in patent law, including topics primarily related to the PTAB.

Megan was the Managing Editor of Virginia Law and Technology at the University of Virginia School of Law. Before law school, Megan was a research fellow at the National Institutes of Health in the U.S. Food and Drug Administration's Laboratory of Immunoregulation (Center for Biologics, Evaluation, and Research), where she co-authored papers on vaccine design and development.

© 2022 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy